.svg)
Health officials have triggered an emergency response in Kent following a rapid rise in meningitis cases, with the UK Health Security Agency (UKHSA) now coordinating a national effort to contain the cluster.
The number of notified cases of invasive meningococcal disease linked to Canterbury has reached 20, up from 15 earlier this week. The UKHSA confirmed that while laboratory tests have verified nine cases—six of which are the MenB strain—an additional 11 notifications remain under investigation. The outbreak has claimed two lives: a student at the University of Kent and a Year 13 pupil from Faversham.
Read Also: National Emergency Triggered by Rapid Meningitis B Surge in Kent
The "Super-Spreader" Investigation
UKHSA Chief Executive Susan Hopkins described the situation as behaving like a "super-spreader event," citing the "explosive nature" of the transmission within student social circles. While the bacteria typically requires prolonged close contact to spread, experts are investigating why this specific cohort has seen such an unprecedented spike in infections following events at Club Chemistry between March 5 and 7.
Read Also: UK Braces for Student Vaccine Overhaul as Kent Meningitis Cluster Exposes National Immunity Gap
Secondary Campus Confirmation
Canterbury Christ Church University has now officially confirmed that one of its students is among those affected. In a direct response, the university has identified and supported close contacts, advising them to seek the same preventative antibiotics already being distributed at the University of Kent. Despite the expansion to a second campus, health officials maintain that the risk to the general public who were not in close contact with the confirmed cases remains low.
Targeted Vaccination Strategy
A historic "targeted" vaccination programme launched today at the University of Kent, offering the MenB jab to approximately 5,000 students residing in campus halls. This move addresses a significant "immunity gap": because the MenB vaccine was only added to the UK’s routine infant schedule in 2015, almost the entire current university population lacks protection.
The National Supply and Policy Shift
The outbreak has caused a surge in private demand, leaving high-street pharmacies like Boots and Superdrug facing significant stock shortages. In response, Health Secretary Wes Streeting confirmed that the Joint Committee on Vaccination and Immunisation (JCVI) has been tasked with an urgent review. This assessment will determine if the national immunisation policy should be permanently changed to include older teenagers and young adults in the MenB schedule.
What Happens Next
The "incubation window" for those exposed in early March is expected to close around March 21. Until then, GPs across the UK remain on high alert for returning students displaying symptoms. Public health teams are focusing on completing the 5,000-dose vaccine rollout while monitoring laboratory results for the 11 suspected cases currently under investigation.
